# Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

> **NCT02077621** · PHASE2 · WITHDRAWN · sponsor: **PhytoHealth Corporation**

## Conditions studied

- Cancer
- Surgery
- Fatigue

## Interventions

- **DRUG:** PG2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02077621
- **Lead sponsor:** PhytoHealth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study reevaluation
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02077621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02077621, "Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02077621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
